Seroprevalence ofEntamoeba histolyticaat a voluntary counselling and testing centre in Tokyo: a cross-sectional study

Author:

Yanagawa Yasuaki,Nagashima Mami,Gatanaga Hiroyuki,Kikuchi Yoshimi,Oka Shinichi,Yokoyama Keiko,Shinkai Takayuki,Sadamasu Kenji,Watanabe KojiORCID

Abstract

BackgroundAmebiasis, which is caused byEntamoeba histolytica, is a re-emerging public health issue owing to sexually transmitted infection (STI) in Japan. However, epidemiological data are quite limited.MethodsTo reveal the relative prevalence of sexually transmittedE. histolyticainfection to other STIs, we conducted a cross-sectional study at a voluntary counselling and testing (VCT) centre in Tokyo. Seroprevalence ofE. histolyticawas assessed according to positivity with an ELISA forE. histolytica-specific IgG in serum samples collected from anonymous VCT clients.ResultsAmong 2083 samples, seropositive rate forE. histolyticawas 2.64%, which was higher than that for HIV-1 (0.34%, p<0.001) and comparable to that for syphilis (rapid plasma reagin (RPR) 2.11%, p=0.31). Positivity forChlamydia trachomatisin urine by transcription-mediated amplification (TMA) was 4.59%. Seropositivity forE. histolyticawas high among RPR/Treponema pallidumhemagglutination (TPHA)-positive individuals and it was not different between clients with and without other STIs. Both seropositivity ofE. histolyticaand RPR were high among male clients. The seropositive rate for anti-E. histolyticaantibody was positively correlated with age. TMA positivity for urineC. trachomatiswas high among female clients and negatively correlated with age. Regression analysis identified that male sex, older age and TPHA-positive results are independent risk factors ofE. histolyticaseropositivity.ConclusionsSeroprevalence ofE. histolyticawas 7.9 times higher than that of HIV-1 at a VCT centre in Tokyo, with a tendency to be higher among people at risk for syphilis infection. There is a need for education and specific interventions against this parasite, as a potentially re-emerging pathogen.

Funder

National Center for Global Health and Medicine

Japan Agency for Medical Research and Development

Publisher

BMJ

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3